EMEA-000783-PIP01-09-M04

Key facts

Invented name
Trulicity
Active substance
dulaglutide
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0227/2016
PIP number
EMEA-000783-PIP01-09-M04
Pharmaceutical form(s)
Solution for injection (pre-filled pen)
Condition(s) / indication(s)
Treatment of type-2 diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Eli Lilly & Company
United Kingdom
Tel. +44 (0)1276 483000
E-mail: eu_paediatric@lilly.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating